By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



52 rue de la Boétie

  Paris  75008   France
Phone: 33-0-1-56-88-52-86 Fax: 33-0-1-56-88-52-81



Company News
Lysogene Release: Biotech Receives Rare Pediatric Disease Designation From FDA For LYS-GM101 For Treatment Of GM1 Gangliosidosis 1/18/2017 7:31:40 AM
Lysogene Appoints David Schilansky To Board Of Directors 12/8/2016 10:20:42 AM
Lysogene Expands Senior Leadership In The USA To Support Its International Development Strategy 10/3/2016 11:28:52 AM
Lysogene Begins Multi-National Observational Study As It Prepares To Initiate Pivotal Clinical Trial For The Treatment Of Sanfilippo Type A 7/6/2016 10:13:18 AM
Lysogene Appoints Dr. Kimberley S. Gannon As Chief Scientific Officer 6/20/2016 9:34:18 AM
Lysogene Creates A Medical And Regulatory Department 2/2/2016 11:52:28 AM
Lysogene Wins The Deloitte In Extenso Technology Fast 50 “Biotech Of The Future” Award For The Paris, France Region 11/30/2015 10:33:16 AM
Lysogene Receives Orphan Drug Designation And Rare Pediatric Disease Designation From The FDA 11/24/2015 9:48:25 AM
Lysogene Forms Solid Financial Team With Two Senior Appointments 11/9/2015 1:14:35 PM
Lysogene And Alcyone Lifesciences (PRCT) Enter Into A Collaboration For Mucopolysaccharidosis Type IIIA (MPS IIIA) 7/22/2015 10:32:46 AM